Cardio Total Liab from 2010 to 2024

CDIOW Stock  USD 0.10  0.04  69.78%   
Cardio Diagnostics Total Liabilities yearly trend continues to be fairly stable with very little volatility. Total Liabilities will likely drop to about 1.1 M in 2024. Total Liabilities is the total amount of all liabilities that Cardio Diagnostics Holdings has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2010-12-31
Previous Quarter
1.5 M
Current Value
1.1 M
Quarterly Volatility
512.1 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cardio Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cardio Diagnostics' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 117.2 K or Selling General Administrative of 7.3 M, as well as many indicators such as Price To Sales Ratio of 1.8 K, Dividend Yield of 0.0 or PTB Ratio of 10.14. Cardio financial statements analysis is a perfect complement when working with Cardio Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Cardio Diagnostics Correlation against competitors.

Latest Cardio Diagnostics' Total Liab Growth Pattern

Below is the plot of the Total Liab of Cardio Diagnostics Holdings over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Cardio Diagnostics' Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cardio Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Cardio Total Liab Regression Statistics

Arithmetic Mean586,452
Geometric Mean428,332
Coefficient Of Variation87.32
Mean Deviation367,657
Median386,010
Standard Deviation512,110
Sample Variance262.3B
Range1.9M
R-Value0.56
Mean Square Error194.8B
R-Squared0.31
Significance0.03
Slope63,789
Total Sum of Squares3.7T

Cardio Total Liab History

20241.1 M
20231.5 M
20221.9 M
202133.9 K

About Cardio Diagnostics Financial Statements

Cardio Diagnostics investors use historical fundamental indicators, such as Cardio Diagnostics' Total Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Cardio Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Liabilities1.5 M1.1 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Cardio Stock Analysis

When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.